Skip to content

Clinical observation of Wenyun Decoction in treating obese polycystic ovary syndrome

Observation on the clinical effect of Wenyun Decoction in the treatment of obese polycystic ovary syndrome based on Xu's theory of Fuyang

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043550
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for obese polycystic ovary syndrome; 2. Comply with the syndrome differentiation standard of deficiency of kidney yang and mutual congestion of phlegm and blood stasis in TCM; 3. The course of the disease is within 2 years; 4. Patients (gender) between 18 and 35 years old; 5. Patients who have signed an informed consent form. 6. If the subject has used weight loss drugs (such as orlistat, liraglutide, etc.), anti-androgen drugs (Diane-35, spironolactone, etc.), ovulation induction within 1 month before being included in the study Drugs (clomiphene, etc.) can be included in this study after a 3-month drug wash-out period.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness and severe diseases such as cardiovascular, cerebrovascular, liver, and hematopoietic system; 2. Allergic constitution, or pregnant or lactating women; 3. Patients who participated in other clinical trials within the past 3 months; 4. People with mental illness; 5. Those with contraindications to metformin hydrochloride tablets.

Design outcomes

Primary

MeasureTime frame
Visceral fat area;Therapeutic effect of TCM syndromes;

Secondary

MeasureTime frame
Subcutaneous fat area;laboratory inspection;Menstrual condition;

Countries

China

Contacts

Public ContactYucheng Yang

Longhua Hospital Shanghai University of Traditional Chinese Medicine

413955458@qq.com+86 13916875272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026